Cargando…

An Improved Animal Model of Multiple Myeloma Bone Disease

SIMPLE SUMMARY: Multiple myeloma is a plasma cell cancer involving bone destruction and is considered an incurable disease despite significant improvements in therapeutic strategies. During myeloma progression, over 90% of patients develop a bone disease that causes patient injury and death. There a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehdi, Syed Hassan, Morris, Carol A, Lee, Jung Ae, Yoon, Donghoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428359/ https://www.ncbi.nlm.nih.gov/pubmed/34503090 http://dx.doi.org/10.3390/cancers13174277

Ejemplares similares

Animal Models of Multiple Myeloma Bone Disease
por: Mehdi, Syed Hassan, et al.
Publicado: (2021)

The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression
por: Mehdi, Syed Hassan, et al.
Publicado: (2023)

Multiple Myeloma of the Orbit
por: Hassan, Mona, et al.
Publicado: (2012)

Multiple Myeloma Associated Bone Disease
por: Rasch, Stine, et al.
Publicado: (2020)

Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease
por: Ji, Bing, et al.
Publicado: (2014)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

Cellular Mechanisms of Multiple Myeloma Bone Disease
por: Oranger, Angela, et al.
Publicado: (2013)

Advanced Imaging of Multiple Myeloma Bone Disease
por: Hansford, Barry G., et al.
Publicado: (2018)

Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)

Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?
por: Nguyen-Pham, Thanh-Nhan, et al.
Publicado: (2012)

Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo
por: Zangari, Maurizio, et al.
Publicado: (2018)

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
por: Bernstein, Zachary S., et al.
Publicado: (2022)

Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer
por: Kim, Nae Yu, et al.
Publicado: (2011)

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
por: Leng, Houfu, et al.
Publicado: (2022)

Computational Modeling of Interactions between Multiple Myeloma and the Bone Microenvironment
por: Wang, Yan, et al.
Publicado: (2011)

Bone-targeted agents in multiple myeloma
por: Nishida, Hiroko
Publicado: (2018)

Gut microbiota deficiency ameliorates multiple myeloma and myeloma-related bone disease by Th17 cells in mice models
por: Liu, Jia, et al.
Publicado: (2023)

Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma
por: Lee, Nuri, et al.
Publicado: (2015)

Genetic factors influencing the risk of multiple myeloma bone disease
por: Johnson, D C, et al.
Publicado: (2016)

Pathogenesis of bone disease in multiple myeloma: from bench to bedside
por: Terpos, Evangelos, et al.
Publicado: (2018)

Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology
por: Raimondi, Lavinia, et al.
Publicado: (2020)

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease
por: Guedes, Alex, et al.
Publicado: (2023)

Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease
por: Garcia-Gomez, Antonio, et al.
Publicado: (2014)

Myeloma Bone Disease
por: Sanderson, Ralph D, et al.
Publicado: (2009)

Vanishing Bone As the Presenting Feature of Multiple Myeloma
por: Thatikonda, Nithisha, et al.
Publicado: (2021)

Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012)

Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement
por: Tosi, Patrizia
Publicado: (2013)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
por: Adamik, Juraj, et al.
Publicado: (2019)

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
por: Lungu, Oxana, et al.
Publicado: (2023)

Potential value of pre-planned imaging of bone disease in multiple myeloma
por: Gundesen, Michael T., et al.
Publicado: (2023)

Bone Cement Augmentation Procedures for Spinal Pathologic Fractures by Multiple Myeloma
por: Ha, Kee-Yong, et al.
Publicado: (2015)

Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
por: Gooding, Sarah, et al.
Publicado: (2019)

The role of bone‐modifying agents in myeloma bone disease
por: Lu, Huifang, et al.
Publicado: (2021)

Validation of a Diagnostic Model to Differentiate Multiple Myeloma from Bone Metastasis
por: Phinyo, Phichayut, et al.
Publicado: (2023)

Local radiotherapy for palliation in multiple myeloma patients with symptomatic bone lesions
por: Lee, Jeong Won, et al.
Publicado: (2016)

Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Newly Developed Multiple Myeloma in a Patient with Primary T-Cell Lymphoma of Bone
por: Hwang, Jun-Eul, et al.
Publicado: (2008)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Ho, Matthew, et al.
Publicado: (2022)

Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5seta54gt2qrf1cvq307ues9m2